139 related articles for article (PubMed ID: 35602)
1. Effect of dopaminergic agonists and antagonists on in vivo cyclic nucleotide content: relation of guanosine 3':5'- monophosphate (cGMP) changes in cerebellum to behavior.
Breese GR; Mueller RA; Mailman RB
J Pharmacol Exp Ther; 1979 May; 209(2):262-70. PubMed ID: 35602
[No Abstract] [Full Text] [Related]
2. Effects of dopaminergic agonists and antagonists on cerebellar guanosine-3',5'-monophosphate (cGMP).
Breese GR; Mailman RB; Ondrusek MG; Harden TK; Mueller RA
Life Sci; 1978 Aug; 23(5):533-6. PubMed ID: 29192
[No Abstract] [Full Text] [Related]
3. Striato-cerebellar pathway controlling cyclic GMP content in the cerebellum: role of dopamine, GABA and enkephalins.
Biggio G; Corda MG; Casu M; Gessa GL
Adv Biochem Psychopharmacol; 1978; 18():227-44. PubMed ID: 206110
[No Abstract] [Full Text] [Related]
4. Depression of some drug-induced in vivo changes of cerebellar guanosine 3',5'-monophosphate by control of motor and respiratory responses.
Lundberg DB; Breese GR; Mailman RB; Frye GD; Mueller RA
Mol Pharmacol; 1979 Mar; 15(2):246-56. PubMed ID: 38389
[No Abstract] [Full Text] [Related]
5. Cyclic nucleotide levels in the rat striatum and cerebellum--in vivo effects of dopamine and acetylcholine receptor agonists and antagonists.
Puri SK; Choma P; Volicer L
Biochem Pharmacol; 1978; 27(19):2333-6. PubMed ID: 215154
[No Abstract] [Full Text] [Related]
6. Dopaminergic supersensitivity in the striatum.
Ungerstedt U; Ljungberg T; Hoffer B; Siggins G
Adv Neurol; 1975; 9():57-65. PubMed ID: 167568
[No Abstract] [Full Text] [Related]
7. Pharmacologically induced changes in the 3':5'-cyclic guanosine monophosphate content of rat cerebellar cortex: difference between apomorphine, haloperidol and harmaline.
Biggio G; Costa E; Guidotti A
J Pharmacol Exp Ther; 1977 Jan; 200(1):207-15. PubMed ID: 13199
[TBL] [Abstract][Full Text] [Related]
8. Changes of rat cerebellar guanosine 3',5'-cyclic phosphate by dopaminergic mechanisms in vivo.
Burkard WP; Pieri L; Haefely W
Adv Biochem Psychopharmacol; 1976; 15():315-24. PubMed ID: 192051
[TBL] [Abstract][Full Text] [Related]
9. Differential sensitivity to morphine-induced analgesia and motor activity in two inbred strains of mice: behavioral and biochemical correlations.
Racagni G; Bruno F; Iuliano E; Paoletti R
J Pharmacol Exp Ther; 1979 Apr; 209(1):111-6. PubMed ID: 219179
[No Abstract] [Full Text] [Related]
10. Actions of dopaminergic agonists on cyclic AMP production in rat brain homogenates.
Iversen LL; Horn AS; Miller RJ
Adv Neurol; 1975; 9():197-212. PubMed ID: 167565
[No Abstract] [Full Text] [Related]
11. Evidence for multiple dopamine receptors involved in the modulation of acetylcholine release in the striatum.
Hársing LG; Vizi ES
Pol J Pharmacol Pharm; 1985; 37(3):383-96. PubMed ID: 2866504
[TBL] [Abstract][Full Text] [Related]
12. Inhibition of the striatum-enriched phosphodiesterase PDE10A: a novel approach to the treatment of psychosis.
Siuciak JA; Chapin DS; Harms JF; Lebel LA; McCarthy SA; Chambers L; Shrikhande A; Wong S; Menniti FS; Schmidt CJ
Neuropharmacology; 2006 Aug; 51(2):386-96. PubMed ID: 16780899
[TBL] [Abstract][Full Text] [Related]
13. Effect of chronic treatment with neuroleptics on the content of 3',5'-cyclic guanosine monophosphate in cerebellar cortex of rats.
Biggio G; Corda MG; Casu M; Gessa GL
Life Sci; 1978 Aug; 23(6):649-52. PubMed ID: 29201
[No Abstract] [Full Text] [Related]
14. Effect of ethanol on cyclic nucleotides in vivo: consequences of controlling motor and respiratory changes.
Breese GR; Lundberg DB; Mailman RB; Frye GD; Mueller RA
Drug Alcohol Depend; 1979; 4(3-4):321-6. PubMed ID: 230951
[TBL] [Abstract][Full Text] [Related]
15. Kainic acid-induced lesion of dopaminergic target cells in the striatum: consequences on the dynamics of cerebellar cGMP.
Biggio G; Corda MG; Casu M; Gessa GL
Naunyn Schmiedebergs Arch Pharmacol; 1978 Aug; 304(1):5-7. PubMed ID: 211448
[TBL] [Abstract][Full Text] [Related]
16. Effect of dopaminephilic agents and cAMP on tyrosine hydroxylase activity.
Goldstein M; Bronaugh RL; Lew JU; Ohashi T; Drummond GS; Fuxe K
Adv Biochem Psychopharmacol; 1977; 16():447-53. PubMed ID: 18892
[No Abstract] [Full Text] [Related]
17. Drug-induced dopaminergic supersensitivity.
Moore KE; Thornburg JE
Adv Neurol; 1975; 9():93-104. PubMed ID: 1146661
[No Abstract] [Full Text] [Related]
18. A critical assessment of behavioural test procedures used to analyse dopaminergic and antidopaminergic drugs.
Nohria V
Methods Find Exp Clin Pharmacol; 1983; 5(6):357-64. PubMed ID: 6137599
[No Abstract] [Full Text] [Related]
19. Effects of dopaminergic agonists and antagonists of feeding in intact and 6-hydroxydopamine-treated rats.
Heffner TG; Zigmond MJ; Stricker EM
J Pharmacol Exp Ther; 1977 May; 201(2):386-99. PubMed ID: 859104
[TBL] [Abstract][Full Text] [Related]
20. Sedative action of low doses of dopaminergic agents.
Maj J; Przewlocka B; Kukulka L
Pol J Pharmacol Pharm; 1977; 29(1):11-21. PubMed ID: 857245
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
